Newsletter | September 19, 2024

09.19.24 -- Accelerating Site Validation And Collaboration With AI And SIP Innovations

Using AI To Speed And Simplify Site Validation

Did you know AI can tap into data to create intelligent site profiles? Combining, comparing, and deriving insights from traditional, structured data and unstructured third-party data brings more context, nuance, and detail to the process, improving the accuracy of site selection.

 

How A Dedicated Medical Affairs Team Drives Site Engagement

Collaboration between sites, sponsors, CROs, and tech providers is crucial for patient delivery. Discover how recent enhancements to the Cognizant® Shared Investigator Platform (SIP) enable streamlined management and improved user experience.

 

Roche Cuts Feasibility Process By 36%

Uncover how an industry pioneer and veteran biotech benefited from Cognizant SIP, including streamlined feasibility questionnaires where principal investigators could spend more time addressing critical, study-specific topics and reduced overall completion time by 36%.

 

VIDEO INSIGHTS

AMR Shares How SIP Transformed Their Trials

Missy MacPhail, Executive Director of Business Development at Alliance for Multispecialty Research, LLC, shares her positive experience with SIP, highlighting how it has benefited AMR.

• Request Information

 

 

 

Discussing SIP With A Renowned Oncologist

Dr. Claudio Cerchione has an insightful conversation with Cognizant’s Head of Global Medical Affairs, discussing how advancements in technology are addressing the challenges faced by research sites in clinical trials and improving overall efficiency in the clinical research process.

• Request Information

 

 

 

SIP: Streamlining Collaboration With Sponsors

In this testimonial, Clinical Site Director at Total Research Group, LLC, Kendaling Bruce, MHSA, describes her experience in efficiently streamlining collaboration with sponsors through the adept utilization of SIP.

• Request Information

 

 

 

Pioneer Clinical Studies' SIP Testimonial

CEO and Site Director of Pioneer Clinical Studies Jeff Somerstein tells how Cognizant's Shared Investigator Platform (SIP) has increased his organization's visibility with sponsors.

• Request Information